Does aprotinin increase the long-term risk of mortality in patients undergoing CABG surgery?

Affiliations

¹ British Heart Foundation Department of Cardiac Surgery, National Heart and Lung Institute, Imperial College, Hammersmith Hospital, London, UK. k.m.taylor@ic.ac.uk

Comment

Ken Taylor. Nat Clin Pract Cardiovasc Med. 2007 Aug.

. 2007 Aug;4(8):416-7.

doi: 10.1038/ncpcardio0934. Epub 2007 Jun 12.

¹ British Heart Foundation Department of Cardiac Surgery, National Heart and Lung Institute, Imperial College, Hammersmith Hospital, London, UK. k.m.taylor@ic.ac.uk

No abstract available

Comment on

Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery.
Mangano DT, Miao Y, Vuylsteke A, Tudor IC, Juneja R, Filipescu D, Hoeft A, Fontes ML, Hillel Z, Ott E, Titov T, Dietzel C, Levin J; Investigators of The Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. Mangano DT, et al. JAMA. 2007 Feb 7;297(5):471-9. doi: 10.1001/jama.297.5.471. JAMA. 2007. PMID: 17284697